36,000 percent stock surge cost him his job July 15

New Post Public Reply Private Reply Replies (2) Message Board
energy_wave caseyryan1986 #711
36,000 percent stock surge cost him his job

Quote:
July 15 (Bloomberg) -- A Wall Street trader said Cynk Technology Corp.’s 36,000 percent stock surge cost him his job, and he blames a short squeeze and regulators who didn’t halt the shares before the company’s value shot past $6 billion.

Tom Laresca, a market-maker at Buckman Buckman & Reid Inc., said he was among traders who thought they spotted a scam as the shares jumped to $2.25 last month from pennies. He sold it short last week around $6 -- which means selling stock you don’t own with a plan to buy it cheaper soon, pocketing the difference. Laresca figured the Securities and Exchange Commission would suspend trading, sending the price toward zero. Cynk has said it’s a social-network service with no revenue and one employee.

“The stock looked worthless, if there’s even a company behind it,” Laresca said. “My 10-year-old knew it was a scam. It was a complete joke.”

Instead of falling, the price more than doubled the next day, July 9, starting the squeeze. Market-makers who had sold the shares short got nervous and scrambled to buy them to close their positions, driving the price even higher, Laresca said. The SEC stopped trading two days later, citing concerns about the accuracy of information in the marketplace and “potentially manipulative transactions.” That was too late, Laresca said.

“When it goes from 6 cents to $16 and you haven’t done anything about it, I’m sorry but you fell asleep at the wheel,” he said. “Everybody knew it. How come they didn’t know it?”
Resigned Today


Judith Burns, an SEC spokeswoman, declined to comment. Laresca said he resigned today after his firm cut his ability to hold positions. He declined to say what the trades cost.

“We temporarily restricted his trading activities,” said Tom Buckman, an executive at the Shrewsbury, New Jersey-based brokerage. “In the firm’s opinion, Mr. Laresca, who is a veteran trader, did not manage his Cynk Technologies position properly.”

A phone message left at Cynk’s corporate number wasn’t returned. The SEC didn’t accuse the company of wrongdoing when halting the stock.

Cynk’s price swings caught the attention of business television hosts, journalists, columnists, bloggers and Twitter pundits. As the valuation passed $5.4 billion, Wall Street blog ZeroHedge called it “pure madness.” That figure was based on the 291 million shares the company says are outstanding.
Market Rules

Only 500,000 of those shares were authorized to trade publicly, according to Cynk’s transfer agent, Pacific Stock Transfer. About $12 million of stock changed hands during the past month, according to data compiled by Bloomberg. The low volume meant that market-makers couldn’t find shares to cover their short positions, Laresca said.

“If you’re short, you have to buy it within five days,” Laresca said of market-making rules. “That’s what was driving the stock higher.”

While Cynk’s $6 billion paper valuation was unusual, spikes and crashes are common in the over-the-counter markets where it traded. Regulators bust alleged pump-and-dump scams there regularly. Many involve defunct companies, or shells, with shares that still trade. The SEC has suspended trading in at least 255 shells this year.

Kevin Kelly, chief investment officer at Recon Capital Partners LLC, which manages about $150 million and issues exchange-traded funds, said Laresca took a risk by shorting Cynk even if he thought it was sketchy.

“He should know that markets can stay irrational longer than you can stay solvent,” Kelly said. “He’s a professional.”
‘Big Game’

Organizers of schemes often slap a new name on the shell and announce they’re in a trendy new business, according to Thomas Sporkin, a former chief of market intelligence at the SEC. Then they distribute stock to associates who’ve agreed to trade it back and forth between themselves to make it look like investors are pushing the stock up, he said. Sometimes they hire promoters to tout the company in e-mails, Twitter postings and on blogs.

“You lure other people into the marketplace, whether they believe it’s legit or they’re just along for the pump and believe they can get out before the dump,” Sporkin said. “It’s like a big game.”
Curb Exchanges

Nathan Michaud, a day trader and one-time stock promoter who runs Investorslive.com, said he didn’t see any signs that Cynk was being promoted. Articles and blog posts pointing out its valuation actually drove the price higher as traders tried to ride the surge, he said.

“The publicity given to this stock after it jumped up from 10 cents to $4 was the cause of this short squeeze,” he said.

The SEC has been fighting penny-stock fraud since the agency’s creation in the 1930s. Its first chairman, Joseph Kennedy, shut down several curb exchanges -- predecessors of today’s over-the-counter markets. In the 1990s, Jordan Belfort and his Stratton Oakmont Inc. defrauded investors out of more than $200 million using cold calls to push stocks, a scheme depicted last year in the movie “The Wolf of Wall Street.”

One of the most prolific promoters in recent years was AwesomePennyStocks, an e-mail list that helped fuel $3 billion in spikes in 39 stocks, most of which now trade for less than a cent, according to data compiled by Bloomberg. In March, the SEC sued John Babikian, a Bugatti-driving 26-year-old, claiming he used the list for a pump-and-dump. He settled this month without admitting or denying wrongdoing, and his lawyer, Stanley Morris, didn’t respond to messages seeking comment. AwesomePennyStocks closed before that case and didn’t promote Cynk.
‘Stupid Things’

Cynk’s auditor in 2012, Peter Messineo, worked for at least two companies promoted by the list, public filings show. Messineo, reached by phone, said he wasn’t aware of those e-mail promotions and doesn’t always follow what happens to shell companies after he audits them.

“Most of those companies go dark,” said Messineo, who hasn’t been accused of wrongdoing. “I have no clue.”

Cynk, which lists headquarters in Belize, as said on its website that it’s a service to buy contact information for people like celebrities.

OTC Markets Group Inc., which runs the trading venue once known as the pink sheets, marks questionable stocks on its website to warn investors. It branded Cynk with a skull and crossbones. Cromwell Coulson, the trading venue’s chief executive officer, who predicted the SEC suspension, said the agency will eventually figure out what happened with Cynk.

“I wish people would just not trade the stupid things,” he said.

To contact the reporters on this story: Zeke Faux in New York at zfaux@bloomberg.net; Jing Cao in New York at hcao38@bloomberg.net

To contact the editors responsible for this story: Peter Eichenbaum at peichenbaum@bloomberg.net; Pui-Wing Tam at ptam13@bloomberg.net David Scheer


http://www.bloomberg.com/news/articles/2014-0...ng-him-job

Calissio Resources Group, Inc. (CRGP) Stock Research Links

CRGP Board Company Profile Buy Rating Time & Sales News Filings Financials
big-wave_surfing_01.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 322

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 174

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 175

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 337

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 296

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 406

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 235

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 317

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 280

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 165

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading

Top 5 Most Recently Viewed Articles

The Rise of Mycoplasma Testing: Future Growth and Trends

Updated Category News Views 102

Insights into the Growth of the Mycoplasma Testing Market The mycoplasma testing market is expected to balloon to USD 2.49 billion in the next few years. This impressive growth stems largely from the increasing use of cell culture techniques within biopharmaceutical research and development. As researchers and companies adopt these advanced methods, the demand for...

Continue Reading
Investors Urged to Examine Claims Against Toronto-Dominion Bank

Updated Category News Views 65

Faruqi & Faruqi Investigates Toronto-Dominion Bank Faruqi & Faruqi, LLP, a prominent national securities law firm, is currently investigating potential claims on behalf of investors who have suffered significant financial losses from their investments in The Toronto-Dominion Bank (NYSE: TD). The firm is reaching out to investors who experienced losses exceeding $100,000,...

Continue Reading
Heifer International Advocates for Farmer Support Amidst Crisis

Updated Category News Views 403

Heifer International Advocates for Farmer Support Amid Climate Crisis Heifer International is calling for urgent action to assist smallholder farmers affected by the extreme weather patterns brought on by climate change. The recent impact of Tropical Depression Sara highlights the vulnerability of agricultural communities across Central America, prompting the organization...

Continue Reading
Mitsubishi Tanabe Pharma Unveils RADICAVA ORS Insights at NASP

Updated Category News Views 135

Mitsubishi Tanabe Pharma America Unveils Data on RADICAVA ORS Mitsubishi Tanabe Pharma America, Inc. (MTPA) is thrilled to share vital information regarding their innovative product, RADICAVA ORS (edaravone), at an upcoming event designed for specialized pharmacy professionals. This presentation aims at enhancing the understanding of it’s application in managing...

Continue Reading
Warren Buffett's Coca-Cola Dividend Strategy: A Love Affair

Updated Category News Views 593

Warren Buffett's Love for Coca-Cola Warren Buffett, a legendary investor, is set to receive a staggering $776 million in dividends from Coca-Cola. This immense wealth from his investment in Coca-Cola illustrates the power of dividends in wealth accumulation. Buffett's investment journey with Coca-Cola has not only been fruitful financially but has also created a personal...

Continue Reading